|
Cell surface markers (%)
|
Negative control 0.1%DMSO
|
Stimulation inducers
|
|---|
|
Positive control LPS
|
BSEO 5 μg/mL
|
BSEO 10 μg/mL
|
VIT- D3
|
|---|
|
CD14
|
2.0 ± 0.3
|
1.7 ± 0.4
|
2.7 ± 0.4
|
3.6 ± 0.3
|
92.7 ± 10.7
|
|
CD11c
|
94.7 ± 1.8
|
95.7 ± 0.2
|
95.0 ± 2.7
|
96.1 ± 0.7
|
94.8 ± 0.5
|
|
HLA-DR
|
96.0 ± 2.1
|
98.8 ± 0.3
|
89.4 ± 15.5
|
91.0 ± 14.2
|
92.7 ± 0.5
|
|
CD83
|
4.49 ± 0.5
|
82.4 ± 1.2
|
4.6 ± 0.9***
|
4.5 ± 2.3***
|
4.4 ± 2***
|
|
CD80
|
49.1 ± 7.3
|
97.0 ± 3.3
|
54.5 ± 7.5***
|
54.8 ± 11.9**
|
55.2 ± 10.4**
|
|
CD86
|
25.8 ± 23.7
|
97.1 ± 2.1
|
24.3 ± 15.0***
|
57.9 ± 13.4***
|
22.7 ± 21.3
|
|
CCR7
|
38.5 ± 19.9
|
73.1 ± 1.9
|
73.4 ± 19.4*
|
45.4 ± 16.4*
|
46 ± 16.2*
|
- Data presented as mean percentages (%) of markers expression of dendritic cells obtained from three different individuals ± SD. Note: (*) Referred to significant difference when compared to the positive control, where *P < 0.05, **P < 0.01, and ***P < 0.001
